SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-018945
Filing Date
2016-05-10
Accepted
2016-05-10 16:12:23
Documents
51
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pbyi-10q_20160331.htm 10-Q 1123966
2 EX-31.1 pbyi-ex311_106.htm EX-31.1 11931
3 EX-31.2 pbyi-ex312_107.htm EX-31.2 11947
4 EX-32.1 pbyi-ex321_109.htm EX-32.1 8893
5 EX-32.2 pbyi-ex322_108.htm EX-32.2 9030
  Complete submission text file 0001564590-16-018945.txt   4586484

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pbyi-20160331.xml EX-101.INS 1072298
7 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20160331.xsd EX-101.SCH 31569
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbyi-20160331_cal.xml EX-101.CAL 31998
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20160331_def.xml EX-101.DEF 78707
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20160331_lab.xml EX-101.LAB 282969
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20160331_pre.xml EX-101.PRE 208045
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35703 | Film No.: 161635910
SIC: 2834 Pharmaceutical Preparations